| Size | Price | Stock | Qty |
|---|---|---|---|
| 500mg |
|
||
| 1g |
|
||
| Other Sizes |
| Targets |
Parabanic acid does not have a specific biological target. It is a human metabolite and a singlet oxygen specific oxidation product. As an imidazolidinone, Parabanic acid is a cyclic urea derivative that may interact with various biological molecules. The compound's role as a human metabolite suggests it is involved in normal metabolic processes. Parabanic acid may be formed through the oxidation of uric acid or other purine metabolites. The compound's biological significance and potential pharmacological effects are not well-characterized. Parabanic acid is used in research and analytical applications.
|
|---|---|
| ln Vitro |
Parabanic acid is not evaluated for direct pharmacological activity in cell-based assays. It is a human metabolite and a chemical intermediate. The compound's utility in research is primarily as a reference standard and as a chemical intermediate in organic synthesis. Parabanic acid is a singlet oxygen specific oxidation product, making it useful in studies of oxidative stress and oxidation reactions. The compound's role as a human metabolite suggests it may be involved in normal metabolic processes, but its biological effects are not well-characterized.
|
| ln Vivo |
Parabanic acid is not used for in vivo pharmacological applications. It is a human metabolite and a chemical intermediate. The compound's applications are limited to research and analytical uses. No in vivo pharmacological studies have been reported for this compound. Parabanic acid is for research use only and is not for human therapeutic use.
|
| Enzyme Assay |
Parabanic acid does not have established receptor binding or enzyme inhibition assay protocols. Its properties are characterized by standard analytical methods including NMR, HPLC, and mass spectrometry. Physical properties: molecular weight 114.06 g/mol; molecular formula C3H2N2O3; IUPAC name: imidazolidine-2,4,5-trione; appearance: white needle or prism crystals; melting point: 249°C (decomposes); sublimes at 100°C; solubility: soluble in 20 parts of water and ethanol; slightly soluble in ether.
|
| Cell Assay |
Parabanic acid is not evaluated in cell-based assays as it is not a pharmacologically active agent. If used in cell-based research, it would be as a reference standard or to study its effects on oxidative stress or metabolism. Standard cell culture protocols would apply if cellular effects were to be evaluated.
|
| Animal Protocol |
In vivo studies are not conducted with Parabanic acid as it is a metabolite and chemical intermediate rather than a drug candidate. Any in vivo evaluations would be related to its role as a human metabolite.
|
| ADME/Pharmacokinetics |
Molecular Weight: 114.06. Formula: C3H2N2O3. CAS No.: 120-89-8. IUPAC Name: imidazolidine-2,4,5-trione. Synonyms: Parabanic acid; 2,4,5-Imidazolinetrione; Imidazolidine-2,4,5-trione; Trioxoimidazolidine; NSC-9789. Appearance: White needle or prism crystals. Melting Point: 249°C (decomposes). Sublimation: 100°C. Solubility: Soluble in 20 parts of water and ethanol; slightly soluble in ether. Storage: Typically at room temperature. Parabanic acid is a human metabolite and singlet oxygen specific oxidation product.
|
| Toxicity/Toxicokinetics |
No toxicology data are available for Parabanic acid as it is a metabolite and chemical intermediate rather than a pharmaceutical compound. The compound is intended for laboratory use only and is not intended for human consumption or therapeutic use. Standard safety precautions for handling chemicals should be followed.
|
| Additional Infomation |
Parabanic acid is an imidazolidinone with the structure imidazoline, substituted with carbonyl groups at positions 2, 4, and 5. It is a human metabolite. It is both an imidazolidinone and a hydrogenated acid, derived from the hydride of imidazoline. Parabanic acid has been reported to be found in tomatoes (Solanum lycopersicum) and Euglena gracilis, and relevant data are available.
Parabanic acid is also known as 2,4,5-Imidazolinetrione, Imidazolidine-2,4,5-trione, Trioxoimidazolidine, NSC-9789, and Parabanic acid [MI]. Its IUPAC name is imidazolidine-2,4,5-trione. Parabanic acid is an imidazolidinone that is substituted by oxo groups at positions 2, 4, and 5. It is a human metabolite and a singlet oxygen specific oxidation product. No clinical trials have been reported for this compound. Parabanic acid is for research use only. |
| Molecular Formula |
C3H2N2O3
|
|---|---|
| Molecular Weight |
114.06
|
| Exact Mass |
114.006
|
| CAS # |
120-89-8
|
| Related CAS # |
60092-26-4
|
| PubChem CID |
67126
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.6±0.1 g/cm3
|
| Melting Point |
249 °C (dec.)(lit.)
|
| Index of Refraction |
1.507
|
| LogP |
-1.99
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
8
|
| Complexity |
155
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O=C1C(N([H])C(N1[H])=O)=O
|
| InChi Key |
ZFLIKDUSUDBGCD-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C3H2N2O3/c6-1-2(7)5-3(8)4-1/h(H2,4,5,6,7,8)
|
| Chemical Name |
imidazolidine-2,4,5-trione
|
| Synonyms |
NSC-9789; NSC 9789; Parabanic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 8.7673 mL | 43.8366 mL | 87.6732 mL | |
| 5 mM | 1.7535 mL | 8.7673 mL | 17.5346 mL | |
| 10 mM | 0.8767 mL | 4.3837 mL | 8.7673 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
